Location: Home
  • search
  • go
  • Relate News
  • 7/27/2021NMPA Issues the Announcement on Certain Matters Related to Drug-Device...
  • 7/27/2021HUTCHMED and AZ Initiate Phase II Trial of ORPATHYS for MET Amplified ...
  • 7/27/2021NASDAQ-listed I-Mab to Seek Dual Listing on Shanghai's STAR Market
  • 7/27/2021Sanofi Secures A New Indication for Renvela (sevelamer) in China
  • 7/27/2021Set Up Steps for Biotech Businesses in China
  • 7/27/2021Understanding "Internet Plus Healthcare" in China: Policy Text Analysi...
  • 7/23/2021Novartis Reports Strong H1 & Q2 Global and China Performance
  • 7/23/2021Roche Reports Flat H1 Performance with Moderate China Drug Sales Growt...
  • 7/23/2021CDE Solicits Comments on the Technical Guidelines for Preparing the Ri...
  • 7/23/2021CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 7/23/2021Menarini AP Acquires China Rights of Cialis (Tadalafil) from Lilly
  • 7/23/2021NMPA Issues the List of Reference Formulations for GQCE Studies (43nd ...
  • 7/23/2021Recent Executive Moves
  • 7/22/2021AI Drug Firm Insilico Mulls IPO in the U.S.
  • 7/22/2021RareStone Submits Chinese NDA of Wakix (pitolisant) for Narcolepsy in ...
  • 7/22/2021Exscientia and GT Apeiron Therapeutics Enter Strategic Oncology R&D Pa...
  • 7/22/2021CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 7/22/2021Aptamer and WuXi AppTec Collaborate to Identify New Optimer Enabled Th...
  • 7/22/2021Merck and Adagene Ink Trial Collaboration and Supply Agreement for Com...
  • 7/22/2021Mabpharm/Sorrento Granted Chinese Approval for Infliximab Biobetter
  • 7/22/2021Ascletis Granted Chinese Approval of PIII Trial of ASC40 Combo with B...
  • 7/22/2021Patent Linkage in China: Up, Running And With Chinese Characteristics
  • 7/20/2021Review of Chinese Pharma Deals, R&D and Regulatory Developments in H1/...
  • 7/20/2021Synthesizing Developments on China's Patent Linkage from the July 15 B...
  • 7/20/2021NMPA Revises Packages Insert of Propranolol Tablets
  • 7/20/2021South Korea's Medipost Drops Joint Venture Plan in China
  • 7/20/2021Eluminex Bio Licenses FibroGen's Biosynthetic Cornea Technology and Re...
  • 7/19/2021CDE Issues the Writing Guidelines and Generic Format of the Production...
  • 7/19/2021Ascentage Enters R&D Deal with the National Cancer Institute for Clin...
  • 7/19/2021Frontier Reports Positive Clinical Results for First Long-acting Injec...
  • Page:177/774 Total number of articles:23207: [First][<<] [175] [176] [177] [178] [179] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group